BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9040475)

  • 1. Screening for glaucomatous visual field loss with frequency-doubling perimetry.
    Johnson CA; Samuels SJ
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):413-25. PubMed ID: 9040475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
    Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which method of flicker perimetry is most effective for detection of glaucomatous visual field loss?
    Yoshiyama KK; Johnson CA
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2270-7. PubMed ID: 9344350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of the dicon screening field to detect eyes with glaucomatous field loss by Humphrey threshold testing.
    Huang AS; Smith SD; Quigley HA
    J Glaucoma; 1998 Jun; 7(3):158-64. PubMed ID: 9627854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve fiber layer thickness in glaucoma patients with asymmetric hemifield visual field loss.
    Badlani V; Shahidi M; Shakoor A; Edward DP; Zelkha R; Wilensky J
    J Glaucoma; 2006 Aug; 15(4):275-80. PubMed ID: 16865002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of frequency doubling perimetry in glaucoma screening of aged 40 or more population].
    Li JJ; Xu L; Zhang RX; Sun XY; Yang H; Zou Y; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2005 Mar; 41(3):221-5. PubMed ID: 15840362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A frequency-doubling perimetric study in normal-tension glaucoma with hemifield defect.
    Kondo Y; Yamamoto T; Sato Y; Matsubara M; Kitazawa Y
    J Glaucoma; 1998 Aug; 7(4):261-5. PubMed ID: 9713784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli.
    Wall M; Kutzko KE; Chauhan BC
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):426-35. PubMed ID: 9040476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of the Glaucoma Hemifield Test in automated perimetry.
    Katz J; Quigley HA; Sommer A
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1658-64. PubMed ID: 7601645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
    Horn FK; Wakili N; Jünemann AM; Korth M
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects.
    Chauhan BC; Johnson CA
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):648-56. PubMed ID: 10067968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
    Realini T; Lai MQ; Barber L
    Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma detection with frequency doubling perimetry and short-wavelength perimetry.
    Horn FK; Brenning A; Jünemann AG; Lausen B
    J Glaucoma; 2007; 16(4):363-71. PubMed ID: 17570999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry.
    Bodis-Wollner I; Brannan JR
    Clin Neurosci; 1997; 4(5):284-91. PubMed ID: 9292257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.